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Antrodia camphorata is a unique mushroom of Taiwan, which has been used as a traditional medicine for protection of diverse
health-related conditions. In an eﬀort to translate this Eastern medicine into Western-accepted therapy, a great deal of work has
been carried out on A. camphorata. This review discusses the biological activities of the crude extracts and the main bioactive
compounds of A. camphorata. The list of bioactivities of crude extracts is huge, ranging from anti-cancer to vasorelaxation
and others. Over 78 compounds consisting of terpenoids, benzenoids, lignans, benzoquinone derivatives, succinic and maleic
derivatives, in addition to polysaccharides have been identiﬁed. Many of these compounds were evaluated for biological activity.
Many activities of crude extracts and pure compounds of A. camphorata against some major diseases of our time, and thus,
a current review is of great importance. It is concluded that A. camphorata can be considered as an eﬃcient alternative
phytotherapeutic agent or a synergizer in the treatment of cancer and other immune-related diseases. However, clinical trails of
human on A.camphorataextractsarelimitedandthoseofpurecompoundsareabsent.Thenextstepistoproducesomemedicines
from A. camphorata, however, the production may be hampered by problems related to mass production.
1.Introduction
About 80% of the world population currently relies on
indigenous or traditional medicines for their primary health
needs, and most of these therapies involve the use of herbal
extracts,ofteninaqueoussolutions[1–3].Antrodia camphor-
ata (Syn. Antrodia cinnamomea) is a fungal parasite on the
inner cavity of the endemic species Cinnamomum kanehirae
(Bull camphor tree) Hayata (Lauraceae) (Figure 1). The host
plantisalargeevergreenbroad-leavedtree,whichonlygrows
in Taiwan, and is distributed over broad-leaved forests at
an altitude of 200–2000m [4]. Cinnamomum kanehirai is a
highqualitymaterialusedtomanufacturevaluablefurniture.
The government has recently protected this endemic tree
species from forest-denudation since this species in nature
is relatively rare [5]. In Taiwan, A. camphorata is called
as “Niu-chang-chih”o r“ Chang-chih”o r“ Niu-chang-ku”o r
“Chang-ku”[ 5]. Locally, it is believed that A. camphorata is
a present from heaven for Taiwanese and, is a well-known
Chinese folk medicine and claimed “ruby in mushroom” in
Taiwan [5]. It grows in the mountain ranges of Taoyuan,
Miaoli, Nantou, Kaohsiung, Taitung and Hualien of Taiwan
[3]. The trophophase of A. camphorata occurs from June
to October [6]. Being a local species, A. camphorata was
historically used in Taiwan by the aborigines as a traditional
prescription for the discomforts caused by alcohol drinking
or exhaustion [5]. Furthermore, the regular consumption is
believed to preserve human vitality and promote longevity.
The preparations from fruiting bodies have been used
for the prevention, or treatment, of numerous diseases
includingliverdiseases,foodanddrugintoxication,diarrhea,
abdominal pain, hypertension, itchy skin and tumorigenic
diseases [7, 8]. The aim of this contribution is to review
the literature covering pharmacological and phytochemical
aspects of A. camphorata.
2. Taxonomical Description
Ku is a Chinese common name meaning mushroom; chih
means a famous Ganoderma-like fungus. Antrodia camphor-
ata was ﬁrst published and identiﬁed as new ganoderma
species, Ganoderma camphoratum, by Zang and Su in 1990
[9]. However, according to fruiting-body morphology and2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Antrodia camphorata from solid-state cultivation of wood. (a) Mycelium from 12-month-old sample. (b) Fruiting bodies from
18-month-old sample. (c) Fruiting bodies from 24-month-old sample. (d) Fruiting bodies from multiple years grown sample.
cultural characteristics, this fungus has been proposed the
name as A. camphorata [5, 10]. In 2004, a phylogenetic
analysis based on sequence data derived from large riboso-
mal subunit sequences of ribosomal RNA genes indicated
that A. camphorata is distantly related to other species
in Antrodia and, consequently, the fungus was transferred
to the new genus Taiwanofungus [11]. However, using
polymorphismanalysisofinternaltranscribedspacerregions
of the ribosomal RNA gene, A. camphorata was reconsidered
as an Antrodia species [12]. The current taxonomic position
of A. camphorata is as follows [13]: Fungi, Basidiomy-
cota, Homobasidiomycetes, Aphyllophorales, Polyporaceae.
Clearly, however, the nomenclature and exact taxonomy
(genus and species) of A. camphorata is still the subject of
debate and needs further research. In this article, we have
chosen the name as A. camphorata to describe this unique
Formosan fungus. The fruiting bodies of A. camphorata
assume diﬀerent plate-like, bell-like, hoof-like or tower-like
shapes. They are ﬂat on the surface of wood at the beginning
of growth. Then the brim of the front edge rises to roll into
plate-shaped or stalactites. The top surfaces of A. camphorata
are lustrous, brown to dark brown in color, with unobvious
wrinkles, ﬂat and blunt edges. The bottom sides are orange
red or partially yellow with ostioles all over [12]. In addition,
A. camphorata exhales strong smell of sassafras (camphor
aroma), becomes pale yellowish brown when sun-dried and
has a strong bitter taste. The red to light cinnamon fruiting
bodies of A. camphorata are bitter and have a mild camphor
scent like the host woods [5]. The mycelia isolated from
the fruiting bodies of A. camphorata form orange red and
orange brown to light cinnamon-colored colonies [5]. The
hyphae of A.camphoratapossessgenerativehyphae2–3.5μm
with clamp connections, and hyaline to light brown skeletal
hyphae up to 4.5 μm wide with weakly amyloid. Basidia, 12–
14 × 3.0–5.0μm, is clavate and 4-sterigmate with a basal
clamp. Basidiospores, 3.5–5.0 × 1.5–2μm, are cylindrical,
hyaline, smooth and sometimes slightly bent [14].
3. Ethnomedicine
Antrodia camphorata has long been used in traditional
medicines of Taiwan for the treatment of twisted tendons
and muscle damage, terriﬁed mental state, inﬂuenza, cold,
headache, fever and many internally aﬃliated diseases [14].
In 1773, a traditional Chinese medical doctor Wu-Sha found
that Taiwan aborigines have often chewed the fruiting bodies
and/or decoction of A. camphorata for the discomfort caused
byexcessalcoholorexhaustionbecauseoflifestyle[14].After
that Dr Wu studied the usage of A. camphorata based on
the locals’ experiences, and began to use it to treat diarrhea,
abdominal pain, hypertension, itchy skin, viral infection,
stomachitis, diabetes mellitus, nephritis, proteinuria, liver
cirrhosis, hepatoma, inﬂuenza, car sickness, calenture and
motion-sickness [7, 15]. After being used for years in
Taiwan, the mushroom is now believed to be a potential
protecting agent for metabolic syndrome. Recently, many
studies have indicated that its medicinal applications go
far beyond the original usage. Therefore, demand for the
fruiting bodies of A. camphorata has far exceeded the supply.
Thus, artiﬁcial cultivation was developed as a substitute.
Currently, A. camphorata is available in three ways, gathering
in the wild fruiting bodies, wood or solid-state cultivation,
and submerged cultivations. Particularly, fruiting bodies and
mycelium produced by A. camphorata wood or solid-stateEvidence-Based Complementary and Alternative Medicine 3
cultivation instead of gathering in the wilds may solve
market’s demand. In Taiwan A. camphorata is commercially
available in the form of fermented wine or pure cultures in
powdered, tablet and capsule form [16].
4. Chemical Constituents
A total of 78 compounds have been identiﬁed and struc-
turally elucidated. Predominant in fruiting bodies are gen-
erally terpenoids in a large number (39 compounds) [17–
25], though there are a few publications on the constituents
of the solid-state cultivated mycelium and, mycelium from
submerged cultivations [26–36]. A large number of triter-
penoid compounds (31 structures) with similar or even
the same structures were described within the last few
years. A common feature of these structures is ergostane
or lanostane skeleton. Due to the high amount of 63%
of terpenoids in the fruiting bodies of A. camphorata, this
group of natural compounds has been in the focus of many
phytochemical studies. Interestingly, no distinct terpenoid
glycosides have ever been isolated from this species; in
contrast to polysaccharides that have been elucidated. Fur-
thermore, several other constituents were described from A.
camphorata comprising benzenoids, lignans, benzoquinones
and maleic/succinic acid derivatives, in addition to polysac-
charides. Finally, sterols, nucleotides and fatty acids were
detected in this species [37–40]. Typical structures and their
activities of isolated constituents from A. camphorata are
depicted in Figure 2 and Table 1,r e s p e c t i v e l y .
5. Pharmacological Effects of CrudeExtracts
The scientiﬁc world’s particular interest in A. camphorata
and its curative properties originated from the realm of
traditional medicine. Ethnic medicine has come to be an
irreplaceable source of knowledge of medicinal mushrooms
and their curative qualities, as well as creating clues for
scientiﬁc research, which usually conﬁrms the legitimacy
of their usage [41, 42]. This part of review will deal with
the pharmacological eﬀects of crude extracts of the A.
camphoratain diﬀerent models of in vivo and invitro studies.
5.1. Anti-Cancer Activities. Both the fruiting bodies and
mycelium of A. camphorata have potent anti-proliferative
activity against various cancers in vitro and in vivo.I t
was indicated that there were multiple potent mechanisms
underlying the anti-cancerous eﬀects of A. camphorata.T h e
crude CHCl3/MeOH extract from fruiting bodies of A.
camphorata exhibited signiﬁcant cytotoxic activity with an
IC50 value of 4.1μgm l −1 against P-388 murine leukemia
cells [18]. The ethylacetate extract from fruiting bodies of A.
camphorata (EAC) exhibited apoptotic eﬀects in two human
liver cancer cell lines, Hep G2 and PLC/PRF/5 in a dose-
dependent manner [43]. In addition, EAC also initiated
mitochondrial apoptotic pathway through regulation of B-
cell lymphoma (Bcl)-2 family proteins expression, release of
cytochrome c, and activation of caspase-9 both in Hep G2
and PLC/PRF/5 cells [43]. Furthermore, EAC also inhibited
the cell survival signaling by enhancing the amount of Iκ-α
in cytoplasm and reducing the level and activity of nuclear
factor (NF)-κB in the nucleus, and subsequently attenuated
the expression of Bcl-XL in Hep G2 and PLC/PRF/5 cells
[43]. Treatment with EAC also caused another human
liver cancer cell line Hep 3B to undergo apoptotic cell
death by way of calcium-calpain-mitochondria signaling
pathway [44]. Another study reported that EAC could
inhibit the invasiveness and metastasis of liver cancer cell
line PLC/PRF/5 cells through the inhibition of angiogenesis
[45]. We previously reported that the CHCl3 extract from
fruiting bodies of A. camphorata (FBAC) showed cytotoxic
activity with an IC50 value of 22, 150, 65 and 95μgml −1,
against cancer cell lines Jurkat, Hep G2, Colon 205 and
MCF 7, respectively. Furthermore, MeOH extract from
FBAC also cytotoxic (IC50 = 40μgml −1) to Jurkat cells [46].
Antrodia camphorata solid-state cultured mycelium (AC-SS,
1μgml −1) showed adjuvant anti-proliferative eﬀects with
cisplatin (10μM) or mitomycin (10μM) in hepatoma cell
lines C3A and PLC/PRF/5 cells (in vitro) and, on xenografted
cells in tumor implanted nude mice (in vivo). Furthermore,
AC-SS showed its adjuvant eﬀects through the inhibition
of MDR gene expressions and the pathway of COX-2-
dependentinhibitionofAKTphosphorylation[47].Interms
of the very recent literature, Lu et al. [48] noted that
ethanol extract from wild fruiting bodies of A. camphorata
(EEAC) dose-dependently induced human premyelocytic
leukemia HL 60 cells apoptosis via histone hypoacetylation,
upregulation of histone deacetyltransferase 1 (HDAC 1),
and downregulation of histone acetyltransferase activities
including GCN 5, CBP and PCAF. Furthermore, combined
treatment with 100nM of trichostatin A (histone deacetylase
inhibitor) and 100μgml −1 EEAC caused synergistic inhi-
bition of cell growth and increase of apoptotic induction
through the upregulation of DR5 and NF-κBa c t i v a t i o n
[48].
There are relatively fewer studies on extracts from
the solid-state or submerged cultivated mycelium or cul-
ture ﬁltrates. Aqueous extract from submerged cultivation
mycelium (SCM) of A. camphorata exhibited signiﬁcant
cytotoxicity against HL-60 cells but not against cultured
human endothelial cells [49]. The SCM resulted dose (25–
150μgml −1) and time-dependent apoptosis, as shown by
loss of cell viability, chromatin condensation and internu-
cleosomal DNA fragmentation in HL-60 cells [50]. Further-
more,apoptosisinthesecellswasaccompaniedbytherelease
of cytochrome c, activation of caspase-3, speciﬁc proteolytic
cleavage of poly (ADP-ribose) polymerase (PARP), and also
with a reduction in the levels of Bcl-2 [50]. In an another
study, the ethanolic extract (0.2–2%, v/v) from solid-state
cultivated mycelia of A. camphorata showed potent anti-
proliferation eﬀect in human non-small cell lung carcinoma
A549cellsbutnotprimaryhumanfetallungﬁbroblastMRC-
5cells[51].Inaddition,thisextracttriggeredtheapoptosisin
the A549 cells by downregulated human galectin-1, human
eukaryotic translation initiation factor 5A, human Rho GDP
dissociation inhibitor α, human calcium-dependent protease
small subunit and human annexin V [51]. To continue, the
eﬀects of A. camphorata on cancer cells was investigated,4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Isolated constituents from A. camphorata. (a) Sesqui- and diterpenoids. (b) Ergostane type triterpenoids. (c) Lanostane-type
triterpenoids. (d) Triterpenoid related compounds. (e) Benzenoids. (f) Lignans and benzoquinone derivatives. (g) Succinic and maleic
derivatives. (h) Miscellaneous compounds.
methanol extract of SCM exhibited the cytotoxicity in Hep
G2 (wild-type p53) and Hep 3B (delete p53) cells with IC50
values of 49.5 and 62.7μgml −1,r e s p e c t i v e l y ,a f t e r4 8ho f
incubation. Cell-cycle analysis revealed that the above SCM
extract treatment induced apoptosis on Hep G2 via G0/G1
cell-cycle arrest followed by the apoptosis through activation
of the caspase-3 and -8 cascades [52]. Furthermore, these
authorsalsoreportedthatthemechanismofMEM-mediated
apoptosis in Hep G2 cells through the Fas/Fas ligand
(FasL) death receptor pathway [53]. In parallel, Chen et
al. [54] noted that the ethanolic extract from SCM has
anti-proliferation against Hep G2 and Hep G3 cells with
54.2 and 82.9μgml −1, respectively. On the other hand,
Yang et al. [55] reported that fermented culture broth
of A. camphorata (FCBAC) exhibits dose (25–150μgml −1)
and time-dependent anti-proliferative eﬀect by induction of
apoptosis in breast cancer cell line MCF-7. In addition, this
apoptic eﬀect is associated with cytochrome c translocation,
caspase-3 activation, PARP degradation and dysregulation
of Bcl-2 and Bax in MCF-7 cells [55]. These authors also
reported that FCBAC has the dose (40–240μgml −1)a n d
time-dependent apoptotic eﬀect in estrogen-nonresponsive
human breast cancer cell line MDA-MB-231 with a similar
kind of mechanism as mentioned above [56]. In addition,
FCBAC treatment also inhibited the cyclooxygenase (COX)-
2 protein expression and prostaglandin E2 (PGE2)p r o -
d u c t i o ni nM D A - M B - 2 3 1c e l l s[ 56]. Furthermore, FCBAC
treatment induced cell-cycle arrest and apoptosis in MDA-
MB-231 both in vitro and in vivo [57]. The A. camphorata
crudeextract(ACCE)at50μgml −1 actsasananti-metastatic
agent, by anti-proliferative through induces G2/M cell-cycle
arrest followed by suppress the active form of matrix metal-
loproteinase (MMP)-9 in bladder cancer cell T24 cells [58].
In addition, ACCE (100μgml −1) showed signiﬁcant anti-
proliferation eﬀect in transitional cell carcinomas (TCC)
cell lines RT4, TSGH-8301 and T24 [59]. In RT4 cells,
100μgml −1 of ACCE showed the p53-independent over
expression of p21 followed by downregulation of pRb. On
the contrary, treatment with ACCE at 50μgml −1 resulted
in downregulations of Cdc2 and Cyclin B1 in the cell
lines TSGH-8301 and T24 [59]. In another study, the
ACCE extract at 150μgml −1 concentration showed anti-
cancer eﬀect in androgen responsive prostate cancer cell line
LNCaP through pathway Akt→p53→p21→CDK4/cyclin
D1→G1/S-phase arrest→apoptosis [60]. In addition, ACCE
also inhibited the androgen independent prostate cancer
cell line PC-3 through G2/M-phase arrest mediated through
pathway p21→cyclin B1/Cdc2 with limited degree of apop-
tosis [60]. Recently, Lu et al. [61] noted that submerged
cultivated A. camphorata extract prevents serum-deprived
PC-12 cell apoptosis through a PKA-dependent pathway
and by suppression of JNK and p38 activities. Ho et al.
[62]r e p o r t e dt h a tc r u d ee x t r a c to fA. camphorata (AC) at
concentrationsof5–50μgml −1 didnotaﬀecttumorcellsPC-
3 viability, but at 100–200μgml −1 decreased viability and
induced apoptosis in a concentration-dependent manner.
In addition, 25–200μgml −1 did not alter basal [Ca2+]i,
however at 25μgml −1 decreased the [Ca2+]i induced by ATP,
bradykinin, histamine and thapsigargin [62]. The mycelia
powder of A. camphorata (MAC) at 25–50μgml −1, did not
aﬀect the cell viability in MG63 human osteosarcoma cells,
however, at 100–200μgml −1 decreased viability and inducedEvidence-Based Complementary and Alternative Medicine 7
apoptosis via inhibition of ERK MAPK phosphorylation
[63].
In summary, extracts of A. camphorata inhibited
markedly intracellular signaling and invasive behavior of
cancer cells. This complexity can also bring signiﬁcant
advantages. For example, certain components in the natural
products can reduce the cytotoxicity of the whole product
(and vice versa). Also, the interaction between diﬀerent
biologically active components can be responsible for their
eﬀects in vivo.D i ﬀerent compounds can modulate unrelated
signaling and therefore, can possess synergistic eﬀects [73].
However, the molecular mechanism(s) has not been fully
elucidated. Further studies are needed to explore the beneﬁts
and safety to cancer patients.
5.2. Anti-Inﬂammatory/Immunomodulatory Eﬀects. Com-
pounds that are capable of interacting with the immune
system to up regulate or down regulate speciﬁc aspects
of the host response can be classiﬁed as immunomodula-
tors or biologic response modiﬁers [74–76]. In peripheral
human neutrophils, extracts from SCM of A. camphorata
displayed anti-inﬂammatory eﬀects by inhibiting reactive
oxygen species (ROS) production with an IC50 ranging from
2–20μgml −1 [77] .T h ea q u e o u se x t r a c tf r o mS C Md o s e -
dependently (25–100μgml −1) inhibited the lipopolysaccha-
ride (LPS)-induced nitric oxide (NO), tumor necrosis factor
(TNF-α), interleukin (IL)-1β and PGE2 production, and
inducible nitric oxide synthase (iNOS) and COX-2 protein
expression via NF-κBp a t h w a y ,i nm a c r o p h a g e s[ 78]. These
results are in parallel to our previous report that CHCl3 (3–
25μgml −1)andMeOH(6–50μgml −1)extractsfromfruiting
bodies of A. camphorata signiﬁcantly inhibited the enhanced
production NO through reducing iNOS expression and,
TNF-α and IL-12 productions from macrophages [46]. Liu
et al. [79] reported that the methanol extract (50μgm l −1)
from wild fruiting bodies have more potency than water
extractsontheanti-inﬂammatoryactivitythroughinhibiting
iNOS, COX-2 and TNF-α expression in mouse microglia
cell line EOC13.31. In addition, the extracts from solid-
state culture were similar to wild-fruiting body in anti-
inﬂammatory activity, but liquid-state fermentation was less
eﬀective [79]. To continue, a hot water extracts (fraction MII
from mycelium, fractions EII and EIII from culture ﬁltrate)
of submerged cultured A. camphorata show dose-dependent
(5–60 μgm l −1) induction of TNF-α and IL-6 in peripheral
blood culture. Furthermore, these fractions at 20 μgm l −1
also showed marked activity in enhancing phagocytosis in
human polymorphonuclear neutrophils (PMN), in addition
to CD11b upregulation, and monocytes [80]. According to
Chang et al. [72] in vivo data, hexane extract (100, 200 and
400 mg kg−1)f r o mS C Mo fA. camphorata has protection
from nephritis by suppression of urine protein and serum
blood urea nitrogen levels and decreased the thickness of
the kidney glomerular basement membrane in SLE-prone
NZB/W F1 mice [72].
5.3. Anti-Hepatitis B Virus Replication. It was reported
that extracts from the mycelium of A. camphorata have
in vivo anti-hepatitis B virus (HBV) activity in a dose-
dependent manner without cytotoxicity [81]. The ethanol
extract displayed anti-HBV eﬀects on both wild-type and
lamivudine-resistant HBV mutants [71]. The ability of A.
camphorata to inhibit the replication of HBV in vivo and
in vitro may be one additional reason for considering this
fungus as a potential therapeutic for HBV infection.
5.4. Anti-Oxidant Activities. Accumulating data have shown
that A. camphorata is a potent direct free radical scav-
enger [82–85]. The stable free radical 1,1-diphenyl-2-
picrylhydrazyl (DPPH) is scavenged by the extracts of A.
camphorata [83, 84] .A q u e o u se x t r a c t so fA. camphorata
inhibited nonenzymatic iron-induced lipid peroxidation in
rat brain homogenates with an IC50 value of 3.1mgml−1
[83]. It has been reported that, compared to other A.
camphorata extracts, the fermented culture broth of A.
camphorata (FCBA) and aqueous extracts of the mycelia
from A. camphorata (AEMA) harvested from submerged
cultures are the most potent inhibitors of lipid peroxidation,
possessing marked free-radical-scavenging activity [82]. The
aqueous extract from SCM of A. camphorata is possessing
anti-oxidant property with respect to oxidative modiﬁca-
tion of human low-density lipoproteins (LDL) in a time-
and concentration-dependent manner [86]. A recent study
reported that FCBA and AEMA at 25–100 μgm l −1 and
50–200μgm l −1, respectively, possess antioxidant properties
in human umbilical vein endothelial cell (EC) culture
system [87]. In addition, both FCBA and AEMA treatment
signiﬁcantly inhibited apoptotic cell death in the ECs, as
evidenced by reduced DNA fragmentation, cytochrome c
release, caspase-3 activation and dysregulation of Bcl-2 and
Bax [87]. Shu and Lung [85] observed the antioxidant activ-
ity (lipid peroxidation, scavenging eﬀect on DPPH radical,
hydroxyl free radicals, superoxide anion, reducing power
activity and chelating eﬀect on ferrous ions) of methanolic
extracts from mycelia and ﬁltrates of A. camphorata at two
diﬀerent concentrations (0.2 and 0.6 mg ml−1). To continue,
2.5 mg ml−1 of methanolic extract irradiated with 20 kGy
γ-rays showed potent anti-oxidant property by scavenging
abilities of 92.3–103% on DPPH radicals [88].
5.5. Hepatoprotective Activity. Ao et al. [89] reviewed the
potential of A. camphorata in treating liver diseases, which
provided the major biologically active constituents and their
eﬀect or mode of action. The fruiting bodies and mycelium
ofA.camphorataareshowntohaveprotectiveactivityagainst
liver hepatitis and fatty liver induced by acute hepatotoxicity
of alcohol [90]. The methanolic extract from wild and
solid-state cultures of A. camphorata exhibited angiotensin-
converting enzyme (ACE) inhibitory activities in sponta-
neously hypertensive rats [91]. The dry matter of submerged
cultivation (DMC) ﬁltrate and aqueous extracts from fruit-
ing bodies have been reported to possess hepatoprotective
activity against liver damage induced by CCl4 [83, 92].
Both of the extracts reduce glutathione (GSH)-dependent
enzymes such as glutathione peroxidase, glutathione reduc-
tase and glutathione S-transferase. Histopathological eval-
uation of the rat liver revealed that the DMC reduced the
incidence of liver lesions, including neutrophil inﬁltration,8 Evidence-Based Complementary and Alternative Medicine
Table 1: Chemical constituents and their reported activities of A. camphorata.
No. Compound name Source Biological activity Ref.
Terpenoids
1 Antrocin F [19]
2 19-Hydroxylabda-8(17)-en-16,15-olide F In vitro neuroprotective [28]
3 3β,19-Dihydroxylabda-8(17),11E-dien-
16,15-olide F In vitro neuroprotective [28]
4 13-epi-3β,19-Dihydroxylabda-8(17),11E-
dien-16,15-olide F In vitro neuroprotective [28]
5 19-Hydroxylabda-8(17),13-dien-16,15-
olide F In vitro neuroprotective [28]
6 14-Deoxy-11,12-
didehydroandrographolide F In vitro neuroprotective [28]
7 14-Deoxyandrographolide F [28]
8 Pinusolidic acid F [28]
9 Antcin A F In vitro anti-inﬂammatory,
anti-insecticidal and cytotoxic [30, 64, 65]
10 Antcin B (Zhankuic acid A) F In vitro anti-inﬂammatory,
anti-insecticidal and cytotoxic
[18, 30, 64–
66]
11 Antcin C F In vitro anti-inﬂammatory and
cytotoxic [65, 67]
12 Antcin D (Zhankuic acid F) F [23]
13 Antcin E F [21]
14 Antcin F F [21]
15 Antcin G F [21]
16 Antcin H (Zhankuic acid C) F In vitro anti-inﬂammatory,
anti-insecticidal and cytotoxic [18, 64–66]
17 Antcin I (Zhankuic acid B) F In vitro anti-inﬂammatory [66]
18 Antcin K F In vitro anti-inﬂammatory [66]
19 Methyl antcinate A F [25]
20 Methyl antcinate B F In vitro anti-insecticidal and
cytotoxic [64, 65]
21 Zhankuic acid D F [25]
22 Methyl antcinate G F [21]
23 Methyl antcinate H F [21]
24 Zhankuic acid E F
25 Dehydroeburicoic acid F In vitro anti-inﬂammatory,
anti-insecticidal [64, 65, 67]
26 Dehydrosulphurenic acid F In vitro anti-insecticidal and
cytotoxic [64, 65]
27 15α-Acetyl-dehydrosulphurenic acid F In vitro anti-insecticidal and
cytotoxic [64, 65]
28 Eburicoic acid F In vitro anti-insecticidal and
cytotoxic [64, 65]
29 Sulphurenic acid F In vitro anti-insecticidal and
cytotoxic [64, 65]
30 Versisponic acid D F
31 Eburicol
(24-methylenedihydrolanosterol) F In vitro anti-inﬂammatory [30]
32 3β,1 5 α-Dihydroxy
lanosta-7,9(11),24-triene-21-oic acid F In vitro anti-insecticidal and
cytotoxic [64, 65]
33 3β-Hydroxy lanosta- F [17]
34 β-Sitosterol F [28]Evidence-Based Complementary and Alternative Medicine 9
Table 1: Continued.
No. Compound name Source Biological activity Ref.
35 β-Sitostenone F [28]
36 Stigmasterol F [28]
37 Ergosterol F [28]
38 Ergosta-4,6,8(14)22-tetraen-3-on3 F [30]
39 epi-Friedelinol F [30]
Benzenoids
40 1,4-Dimethoxy-2,3-methylenedioxy-5-
methylbenzene F In vitro cytotoxic [68]
41 1,4-Dimethoxy-2,3-methylenedioxy-5-
benzoate F[ 24]
42
1,6-Dimethoxy-2,3-methylenedioxy-4-
benzoic
acid
F[ 24]
43 Antrocamphin A F In vitro anti-inﬂammatory [30]
44 Antrocamphin B F [30]
45 2,3,4,5-Tetramethoxybenzoyl chloride F [30]
46 Antrodioxolanone F [30]
47 Isobutylphenol [34]
Lignans
48 (+) Sesamin F [20]
49 4-Hydroxy sesamin F [20]
50 (−) Sesamin F [20]
Benzoquinone derivatives
51 5-Methyl-benzo(1,3)-dioxole-4,7-dione M [20]
52 2-Methoxy-5-methyl(1,4)benzoquinone M In vitro anti-oxidant [20]
53 2,3-Dimethoxy-5-
methyl(1,4)benzoquinone M In vitro anti-inﬂammatory [20, 30]
Succinic and Maleic derivatives
54 trans-3-Isobutyl-4-[4-(3-methyl-2-
butenyloxy)phenyl]pyrrolidine-2,5-dione F In vitro anti-inﬂammatory [33]
55 trans-1-Hydroxy-3-(4-hydoxyphenyl)-4-
isobutylpyrrolidine-2,5-dione F In vitro anti-inﬂammatory [33]
56
3R∗,4S∗-1-Hydroxy-3-isobutyl-4-[4-(3-
methyl-2-
butenyloxy)phenyl]pyrrolidine-2,5-dione
(antrodin D or Camphorataimide E)
F, M In vitro anti-inﬂammatory,
anti-HBV and anti-HCV [29, 33, 69]
57 cis-3-(4-Hydroxyphenyl)-4-
isobutyldihydrofuran-2,5-dione F In vitro anti-inﬂammatory [33]
58 3-(4-Hydroxyphenyl)-4-isobutyl-1H-
pyrrole-2,5-dione F In vitro anti-inﬂammatory [33]
59
3-(4-Hydroxyphenyl)-4-isobutylfuran-
2,5-dione (Antrocinnamomin
C)
F In vitro anti-inﬂammatory [33, 35]
60
3-Isobutyl-4-[4-(3-methyl-2-
butenyloxy)phenyl]furan-2,5-dione
(antrodin A or Camphorataanhydride A)
M In vitro anti-HBV and anti-HCV [29, 69]
61 Dimethyl
2-(4-hydroxyphenyl)-3-isobutylmaleate F In vitro anti-inﬂammatory [33]
62
3-Isobutyl-4-[4-(3-methyl-2-
butenyloxy)phenyl]-1H-pyrrole-2,5-
dione (Antrodin B or Camphorataimide
B)
M, B In vitro anti-inﬂammatory,
anti-HBV and anti-HCV [26, 29, 69]10 Evidence-Based Complementary and Alternative Medicine
Table 1: Continued.
No. Compound name Source Biological activity Ref.
63 Antrocinnamomin D M [35]
64
3-Isobutyl-4-[4-(3-methyl-2-
nyloxy)phenyl]-1H-pyrrol-1-ol-2,5-
dione (antrodin C or) Camphorataimide
C)
M In vitro anti-inﬂammatory,
anti-HBV and anti-HCV [28, 31, 70]
65 Antrocinnamomins A M In vitro anti-inﬂammatory [37]
66
3R∗,4R∗-1-Hydroxy-3-isobutyl-4-[4-(3-
methyl-2-
butenyloxy)phenyl]pyrrolidine-2,5-dione
(Antrodin E or Camphorataimide D)
M In vitro anti-HBV and anti-HCV [31, 70]
67 Antrocinnamomins B M In vitro anti-inﬂammatory [37]
Miscellaneous compounds
68 2,2 ,5,5 -Tetramethoxy-3,4,3 ,4 -bi-
methylenedioxy-6,6 -dimethylbiphenyl F In vitro anti-HBV [71]
69 α-Tocospiro B F [30]
70 Methyl oleate F [20]
71 Antroquinonol M, F In vitro cytotoxic,
anti-inﬂammatory, anti-HBV [12, 32, 72]
72 Adenosine M Prevention of PC 12 cells
apoptosis [37]
73 Cordycepin M [37]
74 2,4,5-trimethoxybenzaldehyde M Prevention of PC 12 cells
apoptosis [31]
75 Antroquinonol B M In vitro anti-inﬂammatory [36]
76 4-acetyl-antroquinonol B M In vitro anti-inﬂammatory [36]
77 2,3-(methylenedioxy)-6-methylbenzene-
1,4-diol M In vitro anti-inﬂammatory [36]
78 2,4-dimethoxy-6-methylbenzene-1,3-diol M In vitro anti-inﬂammatory [36]
F: Fruiting bodies; M: Mycelium; B: Culture broth.
hydropic swelling and necrosis induced by CCl4 [92]. A new
formulation comprising the ﬁltrate of A. camphorata and
extracts from Astragalus membranaceus, Salvia miltiorrhiza
and Lycimm chinense found to have signiﬁcant inhibitory
activity against the elevated ALT level in CCl4-treated
animals to an extent that was even better than when the
ﬁltrate was used alone [93].
Inconclusion,thereporteddatashowedthatA.camphor-
ata may exert its hepatoprotective eﬀects, though diﬀerent
mechanisms such as scavenging free radicals responsible
for cell damage, enhancing the enzymes responsible for
antioxidant activity, inhibiting the inﬂammatory mediators
and/or induction of the regeneration of the liver cells.
Previously reported data revealed that A. camphorata is a
potent free radical scavenger [82–85]. It is therefore possible
that hepatoprotective action of A. camphorata is partially
due to its antioxidant activity. The antioxidant activities of
the ﬁltrate and mycelium extracts were correlated with the
presence of total polyphenols, crude triterpenoids and the
protein/polysaccharide ratio of the crude polysaccharides
[82]. Aqueous extracts of A. camphorata inhibited non-
enzymatic iron-induced lipid peroxidation in rat brain
homogenates with an IC50 value of about 3.1mgml−1 [83].
These results suggest that A. camphorata exerts eﬀective
protectionagainstchemical-inducedhepaticinjuryinvivoby
free radical scavenging activities.
5.6. Prevention of Liver Fibrosis. Using CCl4-treated rats
as an experimental model, it is found that the ﬁltrate of
fermented mycelium from A. camphorata has the preventive
and curative properties of liver ﬁbrosis [94]. Post treatment
with mycelium to CCl4-administered rats clearly accelerated
the reversal of ﬁbrosis and lowered the elevated mRNA
levels of hepatic collagen I, transforming growth factor
(TGF)-β1 and tissue inhibitors of matrix metalloproteinase
(TIMP)-1. Furthermore, it is conﬁrmed that hepatic lipid
peroxidation is increased during ﬁbrogenesis where hepatic
malondialdehyde (MDA) and hydroxyproline (HP) contents
in curative groups were remarkably restored [94]. Another
studyreportedthatfermentedmyceliumiseﬀectiveinrevers-
ing liver ﬁbrosis induced by dimethylnitrosamine (DMN),
while the lowered activities of antioxidative enzymes (SOD,
catalase and GSH-Px) in the liver were not restored [95].
Therefore, more in vivo studies and randomized controlled
clinical studies should be performed to further elucidate the
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5.7. Neuroprotective Eﬀect. It is reported that mycelium
extract from submerged cultivation of A. camphorata pre-
vents serum-deprived PC-12 cell apoptosis through PKA-
dependent pathway and by suppression of JNK and p38
activities [61, 96].
5.8. Antihypertensive Eﬀect. The extracts of wild and solid-
state cultures A. camphorata were obtained by sequential
extraction with cold water (CWS), methanol (MS) and
hot water (HWS), respectively. Among these three, only
extractMS(10mgkg−1 BW)showedpotentantihypertensive
eﬀects in spontaneously hypertensive rats by decreased
systolic blood pressure and diastolic blood pressure, however
these eﬀects were absent in Wistar Kyoto rats [97]. These
results might have a scope to develop A. camphorata
to be a healthy (or functional) food to regulate blood
pressure.
5.9. Vasorelaxation Eﬀect. The SCM extract of strain B85
shown to have concentration-dependent vasorelaxation
with maximal relaxation of 40.34 ± 7.53% through an
endothelium-dependent mechanism, whereas strains 35 398,
35 396 and B71 had mild eﬀects in isolated rat aortic
rings [98]. In conclusion, preclinical and clinical studies are
necessary for the validation of this natural product in the
prevention and/or therapy of above mentioned applications.
Also, the eﬀects of isolated compounds require to be tested
further as discussed subsequently.
6.Bioactivitiesof IsolatedCompounds
6.1. Terpenoids. The bitter components of A. camphorata
are triterpenoids and have known pharmacological activities
(Table 1). Triterpenes are considered to be potential anti-
cancer agents due to activity against growing tumors, they
have direct cytotoxicity against tumor cells rather than to
normal cells. Cultivated mycelium has been reported to
contain similar compounds with wild fruiting bodies [8].
Biological study revealed that zhankuic acids A (10)a n d
C( 16) exhibited cytotoxic activity against P-388 murine
leukemia cells with an IC50 value of 1.8 and 5.4 μgm l −1,
respectively [18]. However, the molecular mechanism(s)
responsible for the inhibitory eﬀects have not been fully
elucidated. We reported that the isolates (10, 16, 20, 25–27,
29 and 32) from fruiting bodies of A. camphorata showed
inhibitory eﬀects on Spodoptera frugiperda Sf9 insect cells
wherezhankuicacidsA(10)andC(16)andmethylantcinate
B( 20) being most potent [64]. In continuation of our
studies on the activities of pure compounds from fruiting
bodies of A. camphorata, these eight compounds together
with antcins A (9)a n dC( 11) were examined for their
cytotoxic data against various cancer cell types. The three
zhankuic acids, 10, 16 and 20 displayed the tumor-speciﬁc
cytotoxicity with an IC50 range from 22.3 to 75.0 μM against
the colon, breast, liver and lung cancer cell lines [65]. One
of the most potent triterpene was methyl antcinate B (20).
Furthermore, compounds 10, 16 and 20 demonstrated to
induce apoptosis in HT-29 cells, as conﬁrmed by sub-G1
cell-cycle arrest as well as DNA fragmentation. Furthermore,
the expression of poly-(ADP-ribose) polymerase cleavage,
Bcl-2 and procaspase-3 were also suppressed, in addition
to their synergistic cytotoxic eﬀect (4 μM each) in HT-29
cells [65]. Our previous results state that the chloroform
extract of A. camphorata demonstrated inhibitory activity on
colon cancer cells (see previously). Analysis suggested that
the active principles in vivo were triterpenoids. These results
indicate that the triterpenoids fraction of A. camphorata
may be a useful ingredient in the treatment of colon cancer.
To continue, our results also reveal that compounds 9, 18
and 20 displayed potential anti-Helicobacter pylori activity
and its associated inﬂammation in human gastric epithelial
AGS cells, by inhibition of adhesion and invasion, NF-κB
activation and the subsequent release of IL-8 in AGS cells
[99].
Antcins A (9) ,B( 10) and eburicol (31) have anti-
inﬂammatory activity by inhibition of N-formylmethionyl-
leucyl-phenylalanine(fMLP)-inducedsuperoxidegeneration
in human neutrophils with an IC50 value of 8.5, 9.8 and
50.5μM, respectively [30]. To continue, antcin C (11), dehy-
droeburicoic acid (25) and eburicoic acid (28) also noted for
their immuno-modulating activity by reduced ROS in the
above mentioned system with IC50 values of 16.9, 144.8 and
43.9, respectively [67]. The compounds 10, 17 and 16 and,
antcin K (18) isolated from ethanol extracts of wild fruiting
body has shown concentration-dependent (1–25μM) anti-
inﬂammatory eﬀects (by modulation of leukocyte activity
and inhibition of ROS) induced by fMLP and TPA in human
neutrophils [66]. The diterpenoid compounds 2, 3, 4, 5 and
6 isolated from the fruiting bodies of A. camphorata have
neuroprotectiveactivityincorticalneuronsfromthecerebral
cortexofHarlanSprague-Dawleyratpupsby39.2,35.0,36.7,
30.6 and 27.0%, respectively, at concentrations between 5
and 20 μM[ 28].
6.2. Maleic and Succinic Acid Derivatives. Nakamura et al.
[24] noted the cytotoxic data of ﬁve new maleic and succinic
acid derivatives from the mycelium of A. camphorata in LLC
tumor cells. The compounds antrodins A (60)a n dD( 56)
had no activity whereas antrodins B (62)a n dC( 64)h a d
cytotoxic activity with ED50 values of 7.5 and 3.6 μgm l −1,
respectively[24].Furthermore,thecompoundsantrodinsA–
E( 56, 60, 62, 64 and 66) from mycelium noted to have anti-
hepatitis activity [27]. The succinic derivative 54 isolated
from fruiting bodies exert both immunostimulatory and
anti-inﬂammatory eﬀects by increased spontaneous TNF-α
secretion from unstimulated RAW264.7 cells, in addition to
suppressed IL-6 production (IC50 = 10 μgm l −1)i nL P S -
stimulated cells. Furthermore, the compounds, 57, 58 and
61 suppressed IL-6 production in LPS-stimulated cells with
IC50 values of 17, 18 and 25 μgm l −1,r e s p e c t i v e l y[ 31].
Antrocinnamomins A (65) isolated from mycelium of A.
camphorata noted to have inhibition of NO production
of macrophages [33]. To continue, the tested maleic and
succinic-acid derivatives 60, 62, 64, 56 and 66 (antrodins
A–E) showed HCV protease inhibitory activity with IC50
values of 0.9, >100, 2.9, 20.0 and 20.1 μgm l −1,r e s p e c t i v e l y
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6.3. Polysaccharides. Polysaccharides represent a structurally
diverse class of biological macromolecules with a wide-
range of physicochemical properties. Polysaccharides of
A. camphorata have been reported to be composed of a
variety of monosaccharides, galactose, glucose, mannose,
glucosamine and galactosamine [38]. The majority of anti-
tumor β-d-glucans isolated from A. camphorata are β-(1→
3)-d-glucopyranans and characteristic β-(1→6)-d-glucosyl
branches [38].
Scientiﬁc investigations concerning the inhibition of
anti-HBV activity by polysaccharides from fruiting bodies
and cultured mycelia of A. camphorata were reported in 2002
[38]. Polysaccharides from strain B86 at a dosage 50 μgm l −1
exhibited the highest anti-hepatitis B surface antigen eﬀect,
whichwashigherthanthatofα-interferonataconcentration
of 1000 U/ml [38]. It is interesting to note that the anti-HBV
activity has not been reported for polysaccharides from any
other mushroom. Thus, further studies on the relationship
between speciﬁc polysaccharide fraction and their biological
activities are required. Recently, extensive studies on the
immunomodulatory and anti-tumor eﬀects polysaccharides
from diﬀerent sources have been reported [100]. For
example, a partially puriﬁed polysaccharide inhibited the
proliferation of human leukemic U937 cells via activation of
human mononuclear cells [101]. In addition, these in vitro
anti-tumor activity was substantiated by the in vivo study
in sarcoma 180-bearing mice where the intraperitoneal and
oraladministrationof100and200mgkg−1 signiﬁcantlysup-
pressed the tumor growth with the inhibition rate of 69.1%
and 58.8%, respectively [101]. Polysaccharides isolated from
A. cinnamomea reported to have anti-angiogenic activities
in endothelial cells, by dose-dependent inhibition of cyclin
D1 expression through vascular endothelial growth factor
receptor signal pathway [102]. To continue, Han et al. [103]
reported that a neutral polysaccharide named ACN2a from
the hot water extract of the mycelium of A. camphorata to
have in vivo hepatoprotective activity in mouse model of
liver injury that was induced by Propionibacterium acnes-
LPS [103]. Another study reported that the polysaccharide
fractions (from SCM), AC-1, AC-2, AC-3, AC-4 and AC-
5 belonged to the category of glycoprotein with mean
molecular mass in the range of 394–940 kDa showed anti-
inﬂammatory activity in macrophages [40]. At a concen-
tration of 1 μm, polysaccharides AC-1 and AC-2 showed
DPPH radical scavenging activity by 74.5 and 50.5%, respec-
tively. In addition, AC-2 dose-dependently (50–200μgm l −1)
inhibit the LPS-induced NO production and iNOS protein
expression in macrophages [40]. Polysaccharides from SCM
possess immunomodulatory activity by modulating the pro-
inﬂammatory cytokines [104], through inducing Th1-type
cytokines such as IFN-γ and TNF-α in a time-dependent
manner but not of Th2 cytokines [70] .Ar e c e n ts t u d y
reported that 3–6 weeks oral administration with 2.5mg
of polysaccharides derived from A. camphorata (AC-PS)
modulate the expression of Th1 cytokines in splenocytes as
well as the type1 diﬀerentiation of T and B lymphocytes, in
addition to reduce the infection rate of Schistosoma mansoni
in mice [105]. Furthermore, water-soluble polysaccharides
(200μgm l −1) from the fermented ﬁltrate and mycelia of
A. cinnamomea signiﬁcantly reduced the oxidative DNA
damage and ROS induced by hydrogen peroxide in Chang
liver cells [106]. A recent study for the ﬁrst time reported the
sulfated polysaccharides (SPSs) from submerged cultivation
medium of A. cinnamomea. These SPSs dose-dependently
inhibited in vitro Matrigel tube formation in an angiogenesis
model, in addition to their prevention of serum-deprived
apoptosis in neuronal-like PC-12 cells [107].
6.4. Compounds with Miscellaneous Biological Activities.
Among the 10 pure compounds (in concentration range
of 5–50 μM) which included one biphenyl, four ergostane-
and ﬁve lanostane derivatives tested for anti-viral activity
againstwild-type(HBsAg)andlamivudine-mutant(HBeAg)
HBV, the only one biphenyl compound (68)a ta5 0 μM
suppressed HBsAg and HBeAg levels by 54.2 and 32.2%,
respectively [71]. The compound adenosine isolated from
ethanolic extract of SCM, noted it acts through adenosine
A2A receptors to prevent rat PC-12 cells from serum
deprivation-induced apoptosis [37]. A benzenoid 2,4,5-
trimethoxybenzaldehyde (74)p r o d u c e db ys u b m e r g e dc u l t i -
vation of A. camphorata reported to has COX-2 inhibitory
activity [31]. The compounds antrocamphin A (43)a n d
2,3-dimethoxy-5-methyl[1, 4]benzoquinone (53) inhibit the
fMLP-induced superoxide generation in human neutrophils
with an IC50 value of 9.3 and 26.1μM, respectively
[30]. Antroquinonol (71), a ubiquinone derivative isolated
from mycelia and the fruiting bodies of A. camphorata
reported to has cytotoxic activities against cancer cell
lines MCF-7, MDA-MB-231, Hep 3B, Hep G2 and DU-
145, LNCaP with the IC50 values ranged from 0.13 to
6.09 μM[ 32]. In addition, 71 at 256 μM signiﬁcantly
inhibited the production of TNF-α and IL-1β by 75 and
78%, respectively, in RAW 264.7 cells [72]. Furthermore,
compound 71 also noted as potent inhibitor in the
synthesis of HBsAg and HBeAg [108]. The compounds
antroquinonol B (75), 4-acetyl-antroquinonol B (76), 2,3-
(methylenedioxy)-6-methylbenzene-1,4-diol (77) and 2,4-
dimethoxy-6-methylbenzene-1,3-diol (78) and antrodin D
(56)frommyceliumofA.camphoratainhibitNOproduction
in LPS-activated macrophages with an IC50 values of 16.2,
14.7, ∼18, 32.2 and 26.3μgm l −1,r e s p e c t i v e l y[ 36]. A
benzenoid compound 40 has dose-dependent (50–150μM)
anti-proliferation activity in human colon cancer cell line
COLO 205 through G0/G1 cell-cycle arrest and induction
of apoptosis (>150 μM). In addition, cell-cycle arrest is
associated with a signiﬁcant increase in levels of p53,
p21/Cip1andp27/Kip1,andadecreaseincyclinsD1,D3and
A[ 68].
7. Summary andOutlook
This review summarized important areas of investigation
being performed on A. camphorata with particular emphasis
on crude extracts and isolated compounds. Some correlation
between the ethnomedical employment and the pharma-
cological activities has been duly observed in the present
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mycelium and cultivation ﬁltrate showed multiple cancer
preventive and anti-inﬂammatory activities. In addition,
these extracts provide a variety of anti-cancer and anti-
inﬂammatory active secondary metabolites and polysaccha-
rides. Of particular promise, due to their potent cytotoxic
activity against a number of cancer cell lines, are the
triterpenoids with ketonic functional groups. In fact, these
triterpenoids, which have also been found in a small number
of other mushrooms, are currently under active investigation
as potential therapeutic leads [109]. Because the antioxidant
action is also a means of lowering chronic anti-inﬂammatory
action, A. camphorata hold potential in functional food
approaches aimed at normalizing metabolic syndrome.
In the search for active compounds from A. camphorata,
the majority of research has been performed on extracts
from the fruiting bodies and mycelium and, there have been
fewer studies on extracts from the submerged cultivated
medium. Further studies would be desirable to isolate
useful new secondary metabolites by varying cultivation
conditions. The pharmacological studies so far have mostly
been performed in vitro and in vivo with animals. Therefore,
clinical studies are needed in order to conﬁrm traditional
wisdom in the light of a rational phytotherapy. Nevertheless,
the former reports could be considered as providing leads
for more scientiﬁc research. The biological activities of the
pure compound administrated or consumed alone were
found to be lower than those obtained from the original
mixture of active ingredients present in natural medicines
including A. camphorata. Thus, the combined, synergistic
eﬀects of a mixture of active components that are present
in A. camphorata on biological activities need to be thor-
oughly assessed. Finally, though we recently developed a
cyclodextrin-modiﬁed capillary electrophoresis method for
theseparationandanalysisofachiralandchiraltriterpenoids
from fruiting bodies of A. camphorata [110], there however,
is a need to establish suitable quality parameters and
analytical methods to determine active compounds.
Acknowledgment
The ﬁrst author would like to thank the Ministry of
Education, Taiwan for supporting her to conduct research in
Taiwan.
References
[1] X. Zhang, WHO Traditional Medicine Strategy 2002–2005,
World Health Organization, Geneva, Switzerland, 2002.
[2] J. C. I. Tsao and L. K. Zeltzer, “Complementary and
alternative medicine approaches for pediatric pain: a review
of the state-of-the-science,” Evidence-Based Complementary
and Alternative Medicine, vol. 2, no. 2, pp. 149–159, 2005.
[3] B. Patwardhan, D. Warude, P. Pushpangadan, and N. Bhatt,
“Ayurveda and traditional Chinese medicine: a comparative
overview,” Evidence-Based Complementary and Alternative
Medicine, vol. 2, no. 4, pp. 465–473, 2005.
[4] T. T. Chang and W. N. Chou, “Antrodia cinnamomea sp. nov.
on Cinnamomum kanehirai in Taiwan,” Mycological Research,
vol. 99, no. 6, pp. 756–758, 1995.
[5] S.-H. Wu, L. Ryvarden, and T.-T. Chang, “Antrodia cam-
phorata (’niu-chang-chih’), new combination of a medicinal
fungus in Taiwan,” Botanical Bulletin of Academia Sinica, vol.
38, no. 4, pp. 273–275, 1997.
[6] J. C. Chen, W. H. Lin, C. N. Chen, S. J. Sheu, S. J. Huang, and
Y. L. Chen, “Development of Antrodia camphorata mycelium
with submerged culture,” Fungal Sciences, vol. 16, pp. 7–22,
2001.
[7] Z. T. Tsai and S. L. Liaw, The Use and the Eﬀect of Ganoderma,
San Yun Press, Taichung, Taiwan, 1985.
[8] C. J. Chen, C. H. Su, and M. H. Lan, “Study on solid
cultivation and bioactivity of Antrodia camphorata,” Fungal
Sciences, vol. 16, pp. 65–72, 2001.
[ 9 ]M .Z a n ga n dQ .H .S u ,“ Ganoderma comphoratum, a new
taxon in genus Ganoderma from Taiwan, China,” Acta
Botanica Yunnanica, vol. 12, pp. 395–396, 1990.
[10] T.-T. Chang and W.-N. Chou, “Antrodia cinnamomea recon-
sidered and A. salmonea s p .n o v .o nCunninghamia konishii
in Taiwan,” Botanical Bulletin of Academia Sinica, vol. 45, no.
4, pp. 347–352, 2004.
[ 1 1 ]S .H .W u ,Z .H .Y u ,Y .C .D a ie ta l . ,“ Taiwanofungus,a
polypore new genus,” Fungal Sciences, vol. 19, pp. 109–116,
2004.
[12] H.-H. Chiu, “Phylogenetic analysis of Antrodia species and
Antrodia camphorata inferred from internal transcribed
spacer region,” Antonie van Leeuwenhoek,v o l .9 1 ,n o .3 ,p p .
267–276, 2007.
[13] D. L. Hawksworth, P. M. Kirk, B. C. Sutton, and D. N. Pegler,
Ainsworth and Bisby’s Dictionary of the Fungi, International
Mycological Institute, Egham, UK, 8th edition, 1995.
[14] C. H. Su, Health Guardian Angel: Antrodia camphorata,E K S
Book Publishing, Taipei, Taiwan, 1st edition, 2002.
[15] J. C. Chen, King of Ganoderma: Antrodia camphorata in
Taiwan, Yuen Chi Jai Book Publishing, Taipei, Taiwan, 2nd
edition, 2008.
[16] J.-J. Cheng, C.-J. Yang, C.-H. Cheng, Y.-T. Wang, N.-K.
Huang, and M.-K. Lu, “Characterization and functional
study of Antrodia camphorata lipopolysaccharide,” Journal of
Agricultural and Food Chemistry, vol. 53, no. 2, pp. 469–474,
2005.
[ 1 7 ]I . - H .C h e r n g ,H . - C .C h i a n g ,M . - C .C h e n g ,a n dY .U .W a n g ,
“Three new triterpenoids from Antrodia cinnamomea,” Jour-
nal of Natural Products, vol. 58, no. 3, pp. 365–371, 1995.
[18] C.-H. Chen, S.-W. Yang, and Y.-C. Shen, “New steroid acids
from Antrodia cinnamomea, a fungal parasite of Cinnamo-
mum micranthum,” Journal of Natural Products, vol. 58, no.
11, pp. 1655–1661, 1995.
[19] C. H. Chiang, D. P. Wu, I. W. Cherng, and U. C. Ueng, “A
sesquiterpenelactone,phenylandbiphenylcompoundsfrom
Antrodia cinnamomea,” Phytochemistry,v o l .3 9 ,n o .3 ,p p .
613–616, 1995.
[20] D. P. Wu and C. H. Chiang, “Constituents of Antrodia
cinnamomea,” JournaloftheChineseChemicalSociety,vol.42,
pp. 797–800, 1995.
[21] I.-H. Cherng, D.-P. Wu, and H.-C. Chiang, “Triterpenoids
from Antrodia cinnamomea,” Phytochemistry,v o l .4 1 ,n o .1 ,
pp. 263–267, 1996.
[22] S.-W. Yang, Y.-C. Shen, and C.-H. Chen, “Steroids and
triterpenoids of Antrodia cinnamomea—a fungus parasitic
on Cinnamomum micranthum,” Phytochemistry, vol. 41, no.
5, pp. 1389–1392, 1996.
[23] Y.-C. Shen, S.-W. Yang, C.-S. Lin, C.-H. Chen, Y.-H. Kuo,
and C.-F. Chen, “Zhankuic acid F: a new metabolite from14 Evidence-Based Complementary and Alternative Medicine
a formosan fungus Antrodia cinnamomea,” Planta Medica,
vol. 63, no. 1, pp. 86–88, 1997.
[24] K.-F.Huang,W.-M.Huang,andH.-C.Chiang,“Phenylcom-
poundsfromAntrodiacinnamomea,” ChinesePharmaceutical
Journal, vol. 53, no. 6, pp. 327–331, 2001.
[25] C. C. Shen, Y. C. Kuo, R. L. Huang et al., “New ergostane and
lanostane from Antrodia camphorata,” The Journal of Chinese
Medicine, vol. 14, pp. 247–58, 2003.
[26] N. Nakamura, A. Hirakawa, J.-J. Gao et al., “Five new maleic
and succinic acid derivatives from the mycelium of Antrodia
camphorata and their cytotoxic eﬀects on LLC tumor cell
line,” Journal of Natural Products, vol. 67, no. 1, pp. 46–48,
2004.
[27] C. C. Shen, H. C. Yang, R. L. Huang, J. C. Chen, and C.
C. Chen, “Anti-HBV principle from the culture broth of
Antrodia camphorata (strain # CCRC-35396),” The Journal of
Chinese Medicine, vol. 16, pp. 57–61, 2005.
[28] C.-C. Chen, Y.-J. Shiao, R.-D. Lin et al., “Neuroprotective
diterpenes from the fruiting body of Antrodia camphorata,”
Journal of Natural Products, vol. 69, no. 4, pp. 689–691, 2006.
[29] M.HattoriandC.C.Sheu,“CompoundsfromAntrodia cam-
phorata having anti-inﬂammatory and anti-tumor activity,”
US 7109232-2006-9-19, 2006.
[30] J.-J. Chen, W.-J. Lin, C.-H. Liao, and P.-C. Shieh, “Anti-
inﬂammatory benzenoids from Antrodia camphorata,” Jour-
nal of Natural Products, vol. 70, no. 6, pp. 989–992, 2007.
[31] C.-C. Chen, C.-C. Chyau, and T.-H. Hseu, “Production
of a COX-2 inhibitor, 2,4,5-trimethoxybenzaldehyde, with
submerged cultured Antrodia camphorata,” Letters in Applied
Microbiology, vol. 44, no. 4, pp. 387–392, 2007.
[32] T.-H. Lee, C.-K. Lee, W.-L. Tsou, S.-Y. Liu, M.-T. Kuo, and
W.-C. Wen, “A new cytotoxic agent from solid-state fer-
mented mycelium of Antrodia camphorata,” Planta Medica,
vol. 73, no. 13, pp. 1412–1415, 2007.
[33] S.-C. Chien, M.-L. Chen, H.-T. Kuo, Y.-C. Tsai, B.-F. Lin,
and Y.-H. Kuo, “Anti-inﬂammatory activities of new succinic
and maleic derivatives from the fruiting body of Antrodia
camphorata,” Journal of Agricultural and Food Chemistry, vol.
56, no. 16, pp. 7017–7022, 2008.
[34] M.-D. Wu, M.-J. Cheng, B.-C. Wang, W.-Y. Wang, J.-T. Lai,
and G.-F. Yuan, “Chemical constituents from the mycelia
of Antrodia cinnamomea,” Journal of the Chilean Chemical
Society, vol. 52, no. 4, pp. 1338–1340, 2007.
[35] M.-D. Wu, M.-J. Cheng, B.-C. Wang et al., “Maleimide and
maleic anhydride derivatives from the mycelia of Antrodia
cinnamomea and their nitric oxide inhibitory activities in
macrophages,” Journal of Natural Products,v o l .7 1 ,n o .7 ,p p .
1258–1261, 2008.
[36] S.-S. Yang, G.-J. Wang, S.-Y. Wang, Y.-Y. Lin, Y.-H. Kuo, and
T.-H. Lee, “New constituents with iNOS inhibitory activity
from mycelium of Antrodia camphorata,” Planta Medica, vol.
75, no. 5, pp. 512–516, 2009.
[37] M.-K. Lu, J.-J. Cheng, W.-L. Lai, Y.-R. Lin, and N.-K. Huang,
“Adenosine as an active component of Antrodia cinnamomea
that prevents rat PC12 cells from serum deprivation-induced
apoptosis through the activation of adenosine A2A recep-
tors,” Life Sciences, vol. 79, no. 3, pp. 252–258, 2006.
[38] I.-H. Lee, R.-L. Huang, C.-T. Chen, H.-C. Chen, W.-C. Hsu,
a n dM . - K .L u ,“ Antrodia camphorata polysaccharides exhibit
anti-hepatitis B virus eﬀects,” FEMS Microbiology Letters, vol.
209, no. 1, pp. 63–67, 2002.
[ 3 9 ]S .C .C h e n ,M .K .L u ,J .J .C h e n g ,a n dD .L .W a n g ,
“Antiangiogenic activities of polysaccharides isolated from
medicinal fungi,” FEMS Microbiology Letters, vol. 249, no. 2,
pp. 247–254, 2005.
[40] C.-C. Chen, Y.-W. Liu, Y.-B. Ker et al., “Chemical charac-
terization and anti-inﬂammatory eﬀect of polysaccharides
fractionated from submerge-cultured Antrodia camphorata
mycelia,” Journal of Agricultural and Food Chemistry, vol. 55,
no. 13, pp. 5007–5012, 2007.
[41] J. Mahajna, N. Dotan, B.-Z. Zaidman, R. D. Petrova, and S.
P. Wasser, “Pharmacological values of medicinal mushrooms
for prostate cancer therapy: the case of Ganoderma lucidum,”
Nutrition and Cancer, vol. 61, no. 1, pp. 16–26, 2009.
[42] U. Lindequist, T. H. J. Niedermeyer, and W.-D. J¨ ulich, “The
pharmacological potential of mushrooms,” Evidence-Based
Complementary and Alternative Medicine, vol. 2, no. 3, pp.
285–299, 2005.
[43] Y.-L. Hsu, Y.-C. Kuo, P.-L. Kuo, L.-T. Ng, Y.-H. Kuo, and C.-
C. Lin, “Apoptotic eﬀects of extract from Antrodia camphor-
ata fruiting bodies in human hepatocellular carcinoma cell
lines,” Cancer Letters, vol. 221, no. 1, pp. 77–89, 2005.
[44] P.-L. Kuo, Y.-L. Hsu, C.-Y. Cho, L.-T. Ng, Y.-H. Kuo, and C.-
C. Lin, “Apoptotic eﬀects of Antrodia cinnamomea fruiting
bodies extract are mediated through calcium and calpain-
dependent pathways in Hep 3B cells,” Food and Chemical
Toxicology, vol. 44, no. 8, pp. 1316–1326, 2006.
[45] Y.-L. Hsu, P.-L. Kuo, C.-Y. Cho et al., “Antrodia cinnamomea
fruiting bodies extract suppresses the invasive potential of
human liver cancer cell line PLC/PRF/5 through inhibition
of nuclear factor κBp a t h w a y , ”Food and Chemical Toxicology,
vol. 45, no. 7, pp. 1249–1257, 2007.
[46] Y. K. Rao, S.-H. Fang, and Y.-M. Tzeng, “Evaluation
of the anti-inﬂammatory and anti-proliferation tumoral
cells activities of Antrodia camphorata, Cordyceps sinensis,
and Cinnamomum osmophloeum bark extracts,” Journal of
Ethnopharmacology, vol. 114, no. 1, pp. 78–85, 2007.
[47] C.-Y. Chang, Z.-N. Huang, H.-H. Yu et al., “The adjuvant
eﬀects of Antrodia camphorata extracts combined with anti-
tumor agents on multidrug resistant human hepatoma cells,”
Journal of Ethnopharmacology, vol. 118, no. 3, pp. 387–395,
2008.
[48] M.-C. Lu, Y.-C. Du, J.-J. Chuu et al., “Active extracts of
wild fruiting bodies of Antrodia camphorata (EEAC) induce
leukemia HL 60 cells apoptosis partially through histone
hypoacetylationandsynergisticallypromoteanticancereﬀect
of trichostatin A,” Archives of Toxicology,v o l .8 3 ,n o .2 ,p p .
121–129, 2009.
[49] Y.-C. Hseu, W.-C. Chang, Y.-T. Hseu et al., “Protection
of oxidative damage by aqueous extract from Antrodia
camphorata mycelia in normal human erythrocytes,” Life
Sciences, vol. 71, no. 4, pp. 469–482, 2002.
[50] Y.-C. Hseu, H.-L. Yang, Y.-C. Lai, J.-G. Lin, G.-W. Chen,
and Y.-H. Chang, “Induction of apoptosis by Antrodia
camphorata in human premyelocytic leukemia HL-60 cells,”
Nutrition and Cancer, vol. 48, no. 2, pp. 189–197, 2004.
[51] H. Wu, C.-L. Pan, Y.-C. Yao, S.-S. Chang, S.-L. Li, and T.-F.
Wu, “Proteomic analysis of the eﬀect of Antrodia camphorata
extract on human lung cancer A549 cell,” Proteomics, vol. 6,
no. 3, pp. 826–835, 2006.
[ 5 2 ] T . - Y .S o n g,S . - L .H s u ,a n dG . - C .Y e n ,“ I n d u c t i o no fa p o p t o s i s
in human hepatoma cells by mycelia of Antrodia camphorata
in submerged culture,” Journal of Ethnopharmacology, vol.
100, no. 1-2, pp. 158–167, 2005.
[ 5 3 ]T .Y .S o n g ,S .L .H s u ,C .T .Y e h ,a n dG .C .Y e n ,“ M y c e l i a
from Antrodia camphorata in submerged culture inducedEvidence-Based Complementary and Alternative Medicine 15
apoptosis of human heptoma Hep G2 cells possibility
through regulation of Fas pathway,” Journal of Agricultural
and Food Chemistry, vol. 53, pp. 5559–5564, 2005.
[54] Y.-S. Chen, J.-H. Pan, B.-H. Chiang, F.-J. Lu, and L.-Y.
Sheen, “Ethanolic extracts of Antrodia cinnamomea mycelia
fermented at varied times and scales have diﬀerential eﬀects
on hepatoma cells and normal primary hepatocytes,” Journal
of Food Science, vol. 73, no. 7, pp. H179–H185, 2008.
[55] H.-L. Yang, C.-S. Chen, W.-H. Chang et al., “Growth
inhibition and induction of apoptosis in MCF-7 breast
cancercellsby Antrodiacamphorata,” CancerLetters,vol.231,
no. 2, pp. 215–227, 2006.
[56] Y.-C. Hseu, S.-C. Chen, P.-C. Tsai et al., “Inhibition of
cyclooxygenase-2 and induction of apoptosis in estrogen-
nonresponsive breast cancer cells by Antrodia camphorata,”
Food and Chemical Toxicology, vol. 45, no. 7, pp. 1107–1115,
2007.
[57] Y.-C. Hseu, S.-C. Chen, H.-C. Chen, J.-W. Liao, and H.-L.
Yang, “Antrodia camphorata inhibits proliferation of human
breast cancer cells in vitro and in vivo,” Food and Chemical
Toxicology, vol. 46, no. 8, pp. 2680–2688, 2008.
[58] C.-C. Peng, K.-C. Chen, R. Y. Peng, C.-H. Su, and H.
M. Hsieh-Li, “Human urinary bladder cancer T24 cells are
susceptible to the Antrodia camphorata extracts,” Cancer
Letters, vol. 243, no. 1, pp. 109–119, 2006.
[59] C.-C. Peng, K.-C. Chen, R. Y. Peng, C.-C. Chyau, C.-H. Su,
and H. M. Hsieh-Li, “Antrodia camphorata extract induces
replicative senescence in superﬁcial TCC, and inhibits the
absolute migration capability in invasive bladder carcinoma
cells,” Journal of Ethnopharmacology, vol. 109, no. 1, pp. 93–
103, 2007.
[60] K.-C. Chen, C.-C. Peng, R. Y. Peng et al., “Unique
formosan mushroom Antrodia camphorata diﬀerentially
inhibits androgen-responsive LNCaP and -independent PC-
3 prostate cancer cells,” Nutrition and Cancer, vol. 57, no. 1,
pp. 111–121, 2007.
[61] M.-K. Lu, J.-J. Cheng, W.-L. Lai, Y.-J. Lin, and N.-K. Huang,
“Fermented Antrodia cinnamomea extract protects rat PC12
cells from serum deprivation-induced apoptosis: the role
of the MAPK family,” Journal of Agricultural and Food
Chemistry, vol. 56, no. 3, pp. 865–874, 2008.
[62] C.-M. Ho, C.-C. Huang, C.-J. Huang et al., “Eﬀects of
Antrodia camphorata on viability, apoptosis, and [Ca
2+]i
in PC3 human prostate cancer cells,” Chinese Journal of
Physiology, vol. 51, no. 2, pp. 78–84, 2008.
[63] Y.-C.Lu,C.-C.Huang, C.-J.Huang et al., “Eﬀects of Antrodia
camphorata on viability, apoptosis, [Ca
2+]i, and MAPKs
phosphorylation in MG63 human osteosarcoma cells,” Drug
Development Research, vol. 68, no. 2, pp. 71–78, 2007.
[ 6 4 ]K .B .M a l e ,Y .K .R a o ,Y . - M .T z e n g ,J .M o n t e s ,A .K a m e n ,
and J. H. T. Luong, “Probing inhibitory eﬀects of Antro-
dia camphorata isolates using insect cell-based impedance
spectroscopy: inhibition vs chemical structure,” Chemical
Research in Toxicology, vol. 21, no. 11, pp. 2127–2133, 2008.
[65] C. T. Yeh, Y. K. Rao, C. F. Yeh et al., “Cytotoxic triterpenes
from Antrodia camphorata and their mode of action in HT-
29 human colon cancer cells,” Cancer Letters, vol. 285, no. 1,
pp. 73–79, 2009.
[66] Y.-C. Shen, Y.-H. Wang, Y.-C. Chou et al., “Evaluation of the
anti-inﬂammatory activity of zhankuic acids isolated from
the fruiting bodies of Antrodia camphorata,” Planta Medica,
vol. 70, no. 4, pp. 310–314, 2004.
[67] Y.-C. Shen, C.-F. Chen, Y.-H. Wang, T.-T. Chang, and C.-
J. Chou, “Evaluation of the immuno-modulating activity of
some active principles isolated from the fruiting bodies of
Antrodia camphorata,” Chinese Pharmaceutical Journal, vol.
55, no. 5, pp. 313–318, 2003.
[68] H. M. Lien, H. W. Lin, Y. J. Wang et al., “Inhibition
of anchorage-independent proliferation and G0/G1 cell-
cycle regulation in human colorectal carcinoma cells by
4,7-dimethoxy-5-methyl-l,3-benzodioxole isolated from the
fruiting body of Antrodia camphorata,” Evidence-Based Com-
plementary and Alternative Medicine, 2009.
[69] D. T. Phuong, C.-M. Ma, M. Hattori, and J. S. Jin, “Short
communication: inhibitory eﬀects of antrodins A-E from
Antrodia cinnamomea and their metabolites on hepatitis c
virusprotease,”PhytotherapyResearch,vol.23,no.4,pp.582–
584, 2009.
[70] Y.-J. Chen, P.-C. Cheng, C.-N. Lin et al., “Polysaccha-
rides from Antrodia camphorata mycelia extracts possess
immunomodulatory activity and inhibits infection of Schis-
tosoma mansoni,” International Immunopharmacology, vol. 8,
no. 3, pp. 458–467, 2008.
[71] R.-L. Huang, Q. Huang, C.-F. Chen, T.-T. Chang, and C.-J.
Chou, “Anti-viral eﬀects of active compounds from Antrodia
camphorata on wild-type and lamivudine-resistant mutant
HBV,”ChinesePharmaceuticalJournal,vol.55,no.5,pp.371–
379, 2003.
[72] J. M. Chang, Y. R. Lee, L. M. Hung et al., “An extract of
Antrodia camphorata mycelia attenuates the progression of
nephritis in systemic lupus erythematosus-prone NZB/W
F1 mice,” Evidence-Based Complementary and Alternative
Medicine, 2008.
[73] G. Aydemir, “Research on nutrition and cancer: the impor-
tance of the standardized dietary assessments,” Asian Paciﬁc
Journal of Cancer Prevention, vol. 3, pp. 177–180, 2002.
[74] P. S. Haddad, G. A. Azar, S. Groom, and M. Boivin, “Natural
health products, modulation of immune function and pre-
vention of chronic diseases,” Evidence-Based Complementary
and Alternative Medicine, vol. 2, no. 4, pp. 513–520, 2005.
[75] A. Vojdani and J. Erde, “Regulatory T cells, a potent
immunoregulatory target for CAM researchers: modulating
tumor immunity, autoimmunity and alloreactive immu-
nity (III),” Evidence-Based Complementary and Alternative
Medicine, vol. 3, no. 3, pp. 309–316, 2006.
[76] S. Kaminogawa and M. Nanno, “Modulation of immune
functions by foods,” Evidence-Based Complementary and
Alternative Medicine, vol. 1, pp. 241–250, 2005.
[77] Y.-C. Shen, C.-J. Chou, Y.-H. Wang, C.-F. Chen, Y.-C. Chou,
and M.-K. Lu, “Anti-inﬂammatory activity of the extracts
from mycelia of Antrodia camphorata cultured with water-
soluble fractions from ﬁve diﬀerent Cinnamomum species,”
FEMSMicrobiologyLetters,vol.231,no.1,pp.137–143,2004.
[78] Y.-C. Hseu, F.-Y. Wu, J.-J. Wu et al., “Anti-inﬂammatory
potential of Antrodia camphorata through inhibition of
iNOS, COX-2 and cytokines via the NF-κBp a t h w a y , ”Inter-
national Immunopharmacology, vol. 5, no. 13-14, pp. 1914–
1925, 2005.
[79] D.-Z. Liu, H.-J. Liang, C.-H. Chen et al., “Comparative anti-
inﬂammatory characterization of wild fruiting body, liquid-
state fermentation, and solid-state culture of Taiwanofungus
camphoratus in microglia and the mechanism of its action,”
Journal of Ethnopharmacology, vol. 113, no. 1, pp. 45–53,
2007.
[80] M.-C. Kuo, C.-Y. Chang, T.-L. Cheng, and M.-J. Wu,
“Immunomodulatory eﬀect of Antrodia camphorata mycelia
and culture ﬁltrate,” Journal of Ethnopharmacology, vol. 120,
no. 2, pp. 196–203, 2008.16 Evidence-Based Complementary and Alternative Medicine
[81] J. C. Chen, C. N. Chen, S. J. Sheu et al., “Liver-caring
medicine containing Antrodia camphorate,” US 0113297-
2003-6-19, 2003.
[82] T.-Y.SongandG.-C.Yen,“AntioxidantpropertiesofAntrodia
camphorata in submerged culture,” Journal of Agricultural
and Food Chemistry, vol. 50, no. 11, pp. 3322–3327, 2002.
[83] G. Hsiao, M.-Y. Shen, K.-H. Lin et al., “Antioxidative and
hepatoprotective eﬀects of Antrodia camphorata extract,”
Journal of Agricultural and Food Chemistry, vol. 51, no. 11,
pp. 3302–3308, 2003.
[84] J.-L. Mau, P.-N. Huang, S.-J. Huang, and C.-C. Chen,
“Antioxidant properties of methanolic extracts from two
kinds of Antrodia camphorata mycelia,” Food Chemistry, vol.
86, no. 1, pp. 25–31, 2004.
[85] C.-H. Shu and M.-Y. Lung, “Eﬀect of culture pH on the
antioxidant properties of Antrodia camphorata in submerged
culture,” Journal of the Chinese Institute of Chemical Engi-
neers, vol. 39, no. 1, pp. 1–8, 2008.
[86] H.-L. Yang, Y.-C. Hseu, J.-Y. Chen et al., “Antrodia camphor-
ata in submerged culture protects low density lipoproteins
against oxidative modiﬁcation,” American Journal of Chinese
Medicine, vol. 34, no. 2, pp. 217–231, 2006.
[87] Y.-C. Hseu, S.-C. Chen, Y.-J. Yech, L. Wang, and H.-
L. Yang, “Antioxidant activity of Antrodia camphorata on
free radical-induced endothelial cell damage,” Journal of
Ethnopharmacology, vol. 118, no. 2, pp. 237–245, 2008.
[88] S.-J. Huang and J.-L. Mau, “Antioxidant properties of
methanolic extracts from Antrodia camphorata with various
doses of γ-irradiation,” Food Chemistry, vol. 105, no. 4, pp.
1702–1710, 2007.
[89] Z.-H. Ao, Z.-H. Xu, Z.-M. Lu, H.-Y. Xu, X.-M. Zhang, and
W.-F. Dou, “Niuchangchih (Antrodia camphorata) and its
potential in treating liver diseases,” Journal of Ethnopharma-
cology, vol. 121, no. 2, pp. 194–212, 2009.
[90] Y.-Y. Dai, C.-H. Chuang, C.-C. Tsai et al., “The protection
of Anthrodia camphorata against acute hepatotoxicity of
alcohol in rats,” Journal of Food and Drug Analysis, vol. 11,
no. 3, pp. 177–185, 2003.
[91] Z.-M. Lu, W.-Y. Tao, X.-L. Zou, H.-Z. Fu, and Z.-H. Ao,
“Protective eﬀects of mycelia of Antrodia camphorata and
Armillariella tabescens in submerged culture against ethanol-
induced hepatic toxicity in rats,” Journal of Ethnopharmacol-
ogy, vol. 110, no. 1, pp. 160–164, 2007.
[92] T.-Y. Song and G.-C. Yen, “Protective eﬀects of fermented
ﬁltrate from Antrodia camphorata in submerged culture
against CCl4-induced hepatic toxicity in rats,” Journal of
Agricultural and Food Chemistry, vol. 51, no. 6, pp. 1571–
1577, 2003.
[93] J. S. Huang, H. C. Chang, E. I. C. Li, T. M. Huang, Y. H. Su,
and K. C. Wang, “Enhancement of hepatoprotective eﬃcacy
ofAntrodiacamphoratabyChinesetraditionmedicine,”Jour-
nalofGastroenterologyandHepatology,vol.21,supplement2,
p. A234, 2006.
[94] W.-C. Lin, S.-C. Kuo, W.-L. Lin, H.-L. Fang, and B.-C. Wang,
“Filtrate of fermented mycelia from Antrodia camphorata
reducesliverﬁbrosisinducedbycarbontetrachlorideinrats,”
World Journal of Gastroenterology, vol. 12, no. 15, pp. 2369–
2374, 2006.
[95] S. Q. Guo, Ameliorative eﬀects of Antrodia camphorata on
liver ﬁbrosis and gastrointestinal functions in rats,M . S .t h e s i s ,
China Medical College, Taiwan, 2002.
[96] N.-K. Huang, J.-J. Cheng, W.-L. Lai, and M.-K. Lu, “Antrodia
camphorata prevents rat pheochromocytoma cells from
serum deprivation-induced apoptosis,” FEMS Microbiology
Letters, vol. 244, no. 1, pp. 213–219, 2005.
[97] D.-Z. Liu, Y.-C. Liang, S.-Y. Lin et al., “Antihypertensive
activities of a solid-state culture of Taiwanofungus cam-
phoratus (Chang-Chih) in spontaneously hypertensive rats,”
Bioscience, Biotechnology and Biochemistry,v o l .7 1 ,n o .1 ,p p .
23–30, 2007.
[98] G.-J. Wang, H.-W. Tseng, C.-J. Chou, T.-H. Tsai, C.-T. Chen,
and M.-K. Lu, “The vasorelaxation of Antrodia camphorata
mycelia: involvement of endothelial Ca
2+-NO-cGMP path-
way,” Life Sciences, vol. 73, no. 21, pp. 2769–2783, 2003.
[ 9 9 ]M .G e e t h a n g i l i ,S .H .F a n g ,C .H .L a i ,Y .K .R a o ,H .M .L i e n ,
and Y. M. Tzeng, “Inhibitory eﬀect of Antrodia camphorata
constituents on the Helicobacter pylori-associated gastric
inﬂammation,” Food Chemistry, vol. 119, no. 1, pp. 149–153,
2010.
[100] I. A. Schepetkin and M. T. Quinn, “Botanical polysac-
charides: macrophage immunomodulation and therapeutic
potential,” International Immunopharmacology, vol. 6, no. 3,
pp. 317–333, 2006.
[101] J.-J. Liu, T.-S. Huang, M.-L. Hsu et al., “Antitumor eﬀects
of the partially puriﬁed polysaccharides from Antrodia
camphorata and the mechanism of its action,” Toxicology and
Applied Pharmacology, vol. 201, no. 2, pp. 186–193, 2004.
[102] J.-J. Cheng, N.-K. Huang, T.-T. Chang, D. L. Wang, and M.-
K.Lu,“Studyforanti-angiogenicactivitiesofpolysaccharides
isolated from Antrodia cinnamomea in endothelial cells,” Life
Sciences, vol. 76, no. 26, pp. 3029–3042, 2005.
[103] H.-F. Han, N. Nakamura, F. Zuo, A. Hirakawa, T. Yokozawa,
and M. Hattori, “Protective eﬀects of a neutral polysaccha-
ride isolated from the mycelium of Antrodia cinnamomea
on Propionibacterium acnes and lipopolysaccharide induced
hepatic injury in mice,” Chemical and Pharmaceutical Bul-
letin, vol. 54, no. 4, pp. 496–500, 2006.
[104] Y.-Y. Wu, C.-C. Chen, C.-C. Chyau, S.-Y. Chung, and
Y.-W. Liu, “Modulation of inﬂammation-related genes of
polysaccharides fractionated from mycelia of medicinal
basidiomycete Antrodia camphorata,” Acta Pharmacologica
Sinica, vol. 28, no. 2, pp. 258–267, 2007.
[105] P.-C. Cheng, C.-Y. Hsu, C.-C. Chen, and K.-M. Lee, “In
vivo immunomodulatory eﬀects of Antrodia camphorata
polysaccharides in a T1/T2 doubly transgenic mouse model
for inhibiting infection of Schistosoma mansoni,” Toxicology
andAppliedPharmacology,vol.227,no.2,pp.291–298,2008.
[106] M.-C. Tsai, T.-Y. Song, P.-H. Shih, and G.-C. Yen, “Antioxi-
dant properties of water-soluble polysaccharides from Antro-
dia cinnamomea in submerged culture,” Food Chemistry, vol.
104, no. 3, pp. 1115–1122, 2007.
[107] J.-J. Cheng, N.-K. Huang, H.-S. Lur, C.-I. Kuo, and M.-K.
Lu, “Characterization and biological functions of sulfated
polysaccharides from sulfated-salt treatment of Antrodia
cinnamomea,” Process Biochemistry, vol. 44, no. 4, pp. 453–
459, 2009.
[108] S.Y.Liu,M.T.Kuo,andW.C.Wen,“InhibitionofhepatitisB
virus by cyclohexenone compounds from Antrodia camphor-
ata,” US US 7411003, 2009.
[109] R. R. M. Paterson, “Ganoderma—a therapeutic fungal
biofactory,” Phytochemistry, vol. 67, no. 18, pp. 1985–2001,
2006.Evidence-Based Complementary and Alternative Medicine 17
[110] E. Majid, K. B. Male, Y.-M. Tzeng, J. O. Omamogho, J.
D. Glennon, and J. H. T. Luong, “Cyclodextrin-modiﬁed
capillary electrophoresis for achiral and chiral separation
of ergostane and lanostane compounds extracted from the
fruiting body of Antrodia camphorata,” Electrophoresis, vol.
30, no. 11, pp. 1967–1975, 2009.